Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.31
-1.86 (-8.79%)
At close: Oct 6, 2026, 4:00 PM EDT
19.64
+0.33 (1.71%)
Pre-market: Oct 7, 2026, 7:00 AM EDT
Immunome Employees
Immunome had 247 employees as of June 30, 2026. The number of employees increased by 92 or 59.35% compared to the same quarter last year.
Employees
247
Change
92
Growth
59.35%
Revenue / Employee
n/a
Profits / Employee
-$1,029,648
Market Cap
2.19B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 247 | 92 | 59.35% |
| Mar 31, 2026 | 206 | 75 | 57.25% |
| Dec 31, 2025 | 177 | 59 | 50.00% |
| Sep 30, 2025 | 168 | 63 | 60.00% |
| Jun 30, 2025 | 155 | 77 | 98.72% |
| Mar 31, 2025 | 131 | 69 | 111.29% |
| Dec 31, 2024 | 118 | 63 | 114.55% |
| Sep 30, 2024 | 105 | 50 | 90.91% |
| Jun 30, 2024 | 78 | - | - |
| Mar 31, 2024 | 62 | 25 | 67.57% |
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Maravai LifeSciences Holdings | 415 |
| Vericel | 398 |
| Vera Therapeutics | 361 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Pharvaris | 148 |
IMNM News
- 15 hours ago - Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 days ago - Immunome initiated with a Hold at Stifel - TheFly
- 6 days ago - Immunome announces IND clearance for IM-1340 in solid tumors - TheFly
- 6 days ago - Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors - Business Wire
- 16 days ago - Immunome initiated with a Buy at Alliance Global - TheFly
- 22 days ago - Immunome Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 27 days ago - Immunome Slides: Corporate presentation - Filings
- 4 weeks ago - Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire